Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Burns: full-pipeline trial registry
9 of 37 indexed Burns trials are currently recruiting.
Corpus placement: #406 of 28,707 conditions by registered trial count.
37 US clinical trials · 9 currently recruiting · #406 of 28,707 conditions by registered trial count
Burns: 37 US clinical trials tracked, 9 recruiting.
Burns is the subject of 37 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 5 of these trials.
Enrollment posture brief
Registry condition burns
OPEN 9 | RECR 24% | LATE 9 | EARLY 9 | RANK #406 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Anatomic Stage IIB Breast Cancer AJCC v8 (24% recruiting · 33 trials)
Burns lists 9 open slots (24% of 37 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Burns on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Burns is recruiting below its size-band peers.
9 of 37 indexed trials (24.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Burns trials is spread across many organizations.
Massachusetts General Hospital accounts for 5 of 37 trials (13.5%). 24 distinct sponsors appear on at least one study for this condition label.
-
Most Burns trials plan to enrol fewer than 100 people.
Median target enrolment is 26 among the 37 trials that report a genuine target (sentinel values excluded). 28 of those (75.7%) plan for fewer than 100 participants.
-
Burns research is mostly interventional.
30 interventional and 7 observational studies make up this index (81.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
37 total, page 1 of 1
Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology
The University of Texas Medical Branch, Galveston
NCT05275335
4-Aminopyridine to Treat Skin Burns
John Elfar
NCT06596434
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
University of Kansas Medical Center
NCT03854344
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
University of Kansas Medical Center
NCT06379724
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Skingenix
NCT01297400
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
The University of Texas Medical Branch, Galveston
NCT06162052
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
The Metis Foundation
NCT05217160
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
The Metis Foundation
NCT05462860
Microsurfaced Grafts in Deep Burn Wounds
CellTherX
NCT04589442
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
PolyNovo Biomaterials Pty
NCT04090424
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
Spaulding Rehabilitation Hospital
NCT05351333
Inflammation and the Host Response to Injury (Trauma)
Massachusetts General Hospital
NCT00257231
Inflammation and the Host Response to Injury (Burns)
Massachusetts General Hospital
NCT00257244
DeepView SnapShot Portable (DV-SSP): Device Training Study
SpectralMD
NCT05023135
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Cumberland Pharmaceuticals
NCT00061633
A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
Avita Medical
NCT01138917
SSD vs Collagenase in Pediatric Burn Patients
Children's Mercy Hospital Kansas City
NCT00787592
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
University of North Carolina, Chapel Hill
NCT00467532
VR for Burn Dressing Changes at Home
Nationwide Children's Hospital
NCT04548635
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
Stratatech, a Mallinckrodt Company
NCT01437852
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Molnlycke Health Care AB
NCT01214811
Virtual Reality in Burn Pain Management
United States Army Institute of Surgical Research
NCT00593086
Vashe Wound Therapy Study
Valleywise Health
NCT00586729
Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes
Ohio State University
NCT02409810
Cranial Electrotherapy Stimulation in Burned Patients
United States Army Institute of Surgical Research
NCT00723008
Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn
United States Army Institute of Surgical Research
NCT00243243
Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients
Massachusetts General Hospital
NCT01500655
Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar
Massachusetts General Hospital
NCT03692273
Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries
PolyNovo Biomaterials Pty
NCT02905435
Burn Outcomes in Young Adult Burn Survivors
Massachusetts General Hospital
NCT01254357
VR for Pain Management During Adult Burn Dressing Change
Nationwide Children's Hospital
NCT04545229
Virtual Reality Hypnosis for Chronic Pain Reduction
University of Washington
NCT01099657
Comparison of Wound Bed Establishment in Facial Burns
University of Louisville
NCT01668030
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
University of Kansas Medical Center
NCT03513406
Amnion Wound Covering for Enhanced Wound Healing
Wake Forest University Health Sciences
NCT03754218
Safety of Extracellular Vesicles for Burn Wounds
Aegle Therapeutics
NCT05078385
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
Stratatech, a Mallinckrodt Company
NCT05517902
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 5 |
| Phase 3 | 4 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Burns records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Burns trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Burns page
37 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Burns trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Burns trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Burns condition card totals 37 registered trials; most-linked intervention Vancomycin or antistaphylococcal penicillin; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.